<?xml version="1.0" encoding="UTF-8"?>
<p>In human medicine, the therapeutic antibodies account for a market of about USD 75 billion [
 <xref rid="B73-antibodies-09-00021" ref-type="bibr">73</xref>]. In contrast, there exists a great economic disparity when it comes to the therapeutic application of rAbs in veterinary medicine. This demands a continuous search for alternative ways to control viral diseases using rAbs in veterinary medicine by focusing on all animal species.
</p>
